Galapagos NV
Below you will find information from the register publication of inside information. The information has been provided by the organisation.
Registration date
28 aug 2023 - 22:08
Statutory name
Galapagos NV
Title
Galapagos announces start of Phase 2 study with selective TYK2 inhibitor, GLPG3667, in patients with active systemic lupus erythematosus
Date last update: 09 April 2026